Table 2.
Overall and Progression-Free Survival Outcomes (n = 53)
| Survival Time | RTOG 0117 Overall Survival |
RTOG 0117 Progression-Free Survival |
RTOG 9410 CON-QD Arm Overall Survival |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Alive | 95% CI | No. at Risk | No. Dead/No. Alive | % Alive | 95% CI | No. at Risk | No. Dead/No. Alive | % Alive | 95% CI | No. at Risk | No. Dead/No. Alive | |
| Time, months | ||||||||||||
| 0 | 100 | 53 | 100 | 53 | 100 | 195 | ||||||
| 3 | 94.3 | 83.5 to 98.1 | 50 | 88.7 | 76.5 to 94.7 | 47 | 95.4 | 91.3 to 97.6 | 186 | |||
| 6 | 88.7 | 76.5 to 94.7 | 47 | 69.8 | 55.5 to 80.3 | 37 | 84.1 | 78.2 to 88.5 | 164 | |||
| 9 | 77.4 | 63.6 to 86.5 | 41 | 52.8 | 38.6 to 65.2 | 28 | 74.4 | 67.6 to 79.9 | 145 | |||
| 12 | 75.5 | 61.5 to 85.0 | 40 | 50.9 | 36.9 to 63.4 | 27 | 62.1 | 54.8 to 68.4 | 120 | |||
| Median survival time, months | 25.9 | 17.1 to NA | 12.2 | 7.2 to 17.4 | 17 | 14.0 to 20.2 | ||||||
| No. of patients surviving at end of study | 28/53 | 36/53 | 185/195 | |||||||||
Abbreviations: RTOG, Radiation Therapy Oncology Group; CON QD, concurrent delivery beginning with day 1; NA, not applicable.